论文部分内容阅读
心钠素(人体α利尿肽,α-hANP)系最近发现的心脏内分泌多肽,具多种心血管作用和利尿及促尿钠排泄作用,但应用于肝硬化腹水病人,国内外尚无报道。本试验首次用心钠素治疗2例肝炎后肝硬化腹水病人,分别进行了2和24小时的利尿观察。治疗过程中,控制病人用药前、后的水与电解质
Atrial natriuretic peptide (α-hANP) is a recently discovered cardiac endocrine polypeptide with a variety of cardiovascular effects and diuresis and natriuresis excretion, but has not been reported in patients with cirrhosis and ascites. The trial for the first time with atrial natriuretic sodium in 2 patients with cirrhosis of liver cirrhosis patients, respectively, for 2 and 24 hours of diuretic observation. In the course of treatment, control the patient’s medication before and after the water and electrolytes